Tech Rally Lifts SP 500 to Record High as Energy and Staples Weigh Consumer Credit Growth Surges in December Amid Holiday Spending Eli Lilly Reports Strong Q1 2026 Earnings Raises FullYear Guidance on Mounjaro Momentum and GLP1 Demand Paul Tudor Jones Says Theres No Chance Kevin Warsh Could Push the Fed to Cut Rates UK Bank Holiday Travel Surge and Warm Weather May Boost Consumer Spending Chinese Inn Owners Face Headwinds in Osaka as Japan Tightens Regulations QUCY Q4 2023 Earnings Narrowing Losses as Mainz Biomed Advances Colorectal Cancer Screening Pipeline HBM Q1 2026 Earnings EPS Beat Driven by Operational Strength and Cost Discipline OSRH Q4 2025 Earnings EPS Misses Estimates by 5686 as Stock Declines 517 Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue Origin Bancorp Inc OBK Q1 2026 Earnings EPS Misses Estimates Amid Interest Rate Headwinds GLNG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Civista Bancshares CIVB Gains 14 as Regional Bank Stock Approaches Key Resistance Level Zedge Inc ZDGE Faces Resistance as Stock Declines 233 Micron Technology MU Surges 1929 Momentum Builds Above Key Support AutoZone Inc AZO Slips 276 as Resistance Holds Support Levels Tested Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline Trump Refiles 10 Billion Lawsuit Against Wall Street Journal Over Epstein Report VSEC Q1 2026 Earnings Strong EPS Beat of 278 Highlights Operational Execution PBF Energy Jumps 26 as Refining Sector Shows Renewed Strength Support Holds AVD Q3 2025 Earnings Significant EPS Miss Amid Challenging Conditions BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Confidence EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates CSV Q1 2026 Earnings EPS Beats Estimate Amid Tight Beat Stock Slips 2 Vista Gold Corp Q1 2026 Earnings PreRevenue Stage Maintains Focus on Paredones Amarillos MGTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline